A New Paradigm for Power in Residential and Commercial Applications

 

Power quality is gaining recognition as a fundamental piece of the overall energy puzzle. To create a full solution, it is no longer enough to have power going into residential and commercial applications; that power quality must be clean.

Joe Piccirilli, Founder and CEO of RoseWater, and Chris Walsh, Director of Global Sales and Marketing for Powervar, understand this need for clean power and spoke to Tyler Kern about moving away from the old power paradigm in these residential and commercial applications and paving a new road with an emphasis on power quality.

Powervar is a commercial power solutions provider for OEMs since 1986. Their driving mission is to ensure quality protection for power sources and make sure their equipment works as it was designed to work.

“We strive on keeping businesses in business,” Walsh said. “The power company can only provide power. They do not ensure that you have clean power within your facility.”

Piccirilli said that many of today’s energy trends and solutions for residential applications begin in the commercial space. And a problem in the commercial world that Walsh referred to as power viruses can impact many businesses, including quick-service restaurants.

These same viruses are spilling into the residential market, too.

“Some of these power viruses we (Powervar) protect are power surges, common-mode voltage, electrical noise, voltage swells or sags, and power outages, which is the only one you can actually see,” Walsh said.

He likens the situation to an iceberg where the power outages are the visible part of the problem, but all the unseen portions of the power virus iceberg are what’s going to sink a ship.

“One of the things I’ve noticed in the residential world is, when we see a power surge or a power sag, a lot of times it will be lights dimming for a quick moment or the lights getting a little brighter because the voltage spiked up a bit,” Piccirilli said.

With more and more energy uses occurring in residential and commercial areas, the need to protect equipment from these power viruses increases, as does the need for installing the right power cleaning solutions.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More